Provided by Tiger Trade Technology Pte. Ltd.

PAVmed

4.43
-0.0950-2.10%
Volume:11.07K
Turnover:48.68K
Market Cap:30.94M
PE:-0.27
High:4.62
Open:4.44
Low:4.23
Close:4.52
52wk High:28.44
52wk Low:3.85
Shares:6.99M
Float Shares:4.42M
Volume Ratio:0.51
T/O Rate:0.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-16.4698
EPS(LYR):-5.6300
ROE:-64.78%
ROA:-39.69%
PB:0.99
PE(LYR):-0.79

Loading ...

PAVmed Launches New At-the-Market Equity Offering

TIPRANKS
·
Yesterday

PAVmed Enters At-the-Market Equity Sales Agreement for up to USD 9.4 Million of Stock

Reuters
·
Yesterday

PAVmed Maintained at Buy as Analyst Sees Long-Term Growth Upside; $16 Price Target Reaffirmed

TIPRANKS
·
Aug 16

PAVmed Reports Q2 2026 Results and Operational Progress

TIPRANKS
·
Aug 14

PAVmed Q2 FY26 GAAP Net Loss Narrows to $5.48 Million; Revenue Rises to $33,000

Reuters
·
Aug 14

PAVmed Q2 Adj. EPS $(0.27) Beats $(0.58) Estimate, Sales $33.000K Miss $72.000K Estimate

Benzinga Earnings
·
Aug 14

Press Release: PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results

Dow Jones
·
Aug 14

PAVmed Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 14

PAVmed Subsidiary Lucid Diagnostics Posts 2Q Revenue of USD 1.5 Million

Reuters
·
Aug 13

Press Release: Lucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results

Dow Jones
·
Aug 13

Lucid Diagnostics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 13

Lucid Diagnostics Q2 FY26 Revenue Rises 25% to USD 1.5 Million

Reuters
·
Aug 13

PAVmed Inc Expected to Post a Loss of 47 Cents a Share - Earnings Preview

Reuters
·
Aug 12

Lucid Diagnostics Inc Expected to Post a Loss of 7 Cents a Share - Earnings Preview

Reuters
·
Aug 11

PAVmed Unit Lucid Diagnostics Wins Concert Commercial Coverage Policy for EsoGuard Test

Reuters
·
Aug 05

Lucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for Its Esoguard® Esophageal DNA Test

THOMSON REUTERS
·
Aug 05

Lucid Diagnostics to Present at Needham, Canaccord Investor Conferences

Reuters
·
Aug 04

Lucid Diagnostics Management Participates in Canaccord Genuity Growth Conference Fireside Chat

Reuters
·
Aug 04

PAVmed to Host Business Update Call, Report Q2 2026 Results

Reuters
·
Jul 31

Lucid Diagnostics Schedules Business Update Call to Discuss Q2 2026 Results

Reuters
·
Jul 30